Skip to main content
. 2018 Jan 15;8:737. doi: 10.1038/s41598-017-18658-3

Figure 5.

Figure 5

TGFβ1 influences respiratory chain activity and spare capacity in myoblasts and myotubes. Primary human myoblasts and myotubes were treated with TGFβ1 (0.25 or 0.5 ng/ml) or SB431542 (10 μM) for 48 hours and processed according to Fig. 2 and high resolution respirometry was carried out. (a) Cytochrome C effect calculated by dividing respiration after addition of cytochrome C by respiration after succinate addition. (b) Respiration rates after the indicated additions in myoblasts and (c) myotubes. (d) Spare respiratory capacity calculated by dividing the difference between ETS and OXPHOS capacity by OXPHOS capacity. For (a and d) one-way ANOVA was performed for each differentiation state. For (b and c) two-way ANOVA was performed. *p < 0.05, **p < 0.01. ***p < 0.001. n = 3–4, mean ± SD.